Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases

26 Nov 2021

Abstract excerpt

Progress in development of prognostic and therapeutic options for the rare cholestatic liver diseases, primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), is hampered by limited knowledge of their pathogeneses. In particular, the potential role of hepatotoxic and/or metabolism-altering environmental chemicals in the pathogenesis of these diseases remains relatively unstudied. Moreover, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver Disease Diagnosis and Treatment
Share to Liver Diseases and Immunity
Share to Pediatric Hepatobiliary Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34825528
DOI: 10.1002/hep4.1871

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver DiseasesPMID 34825528Read ↗

Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitisSemantic proximity Read ↗

Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknownsSemantic proximity Read ↗

Integrated transcriptomics and metabolomics reveal signatures of lipid metabolism dysregulation in HepaRG liver cells exposed to PCB 126Semantic proximity Read ↗

Unraveling MASLD Through the Use of Omics TechnologiesSemantic proximity Read ↗

Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s DiseaseSemantic proximity Read ↗

PFHpA alters lipid metabolism and increases the risk of metabolic dysfunction-associated steatotic liver disease in youth—a translational research frameworkSemantic proximity Read ↗

Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome PathwaysSemantic proximity Read ↗

The Interplay between Endocrine-Disrupting Chemicals and the Epigenome towards Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive ReviewSemantic proximity Read ↗

Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases.Semantic proximity Read ↗

Analytical and Omics-Based Advances in the Study of Drug-Induced Liver InjurySemantic proximity Read ↗

Causal inference of metabolites in autoimmune liver diseases: A Mendelian randomization analysis.Semantic proximity Read ↗

PSC Scientific Community Resource The PSC Scientific Community Resource: An Asset for Multi-Omics Interrogation of Primary Sclerosing CholangitisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.